Most days the wise man will try to learn something he didn’t know when he got up that morning. Sometimes that can be hard work. This morning your correspondent got lucky.
A couple of weeks ago, as noted on this site and in many places elsewhere, Richard J. Ablin, PhD, wrote an OpEd in the New York Times that was received with surprise in some quarters, agreement by not a few, and a great deal of anger in others. But there was something behind this OpEd that The “New” Prostate Cancer InfoLink did not know until this morning so first and foremost here are a couple of links you might want to look at:
Most of the readers of Prof. Ablin’s original OpEd will not have been aware of at least some of the information on these two sites. That would seem to your correspondent to be a great pity, particularly given the fact that Prof. Ablin himself most certainly did first note the existence of antigens to human prostate tissue some 7 years prior to his father’s diagnosis with metastatic disease in 1978.
The “New” Prostate Cancer InfoLink offers its belated condolences to the Ablin family for the demise of Robert Benjamin Ablin.
Like Prof. Ablin, we have long believed that the PSA test is not a test that should be used in the annual, mass, population-based “screening” of all men for prostate cancer. On the other hand, there are most certainly men who for a wide variety of reasons may benefit from regular (and even annual) PSA testing in order to seek the possibility of avoiding what happened to Prof. Ablin’s father.
For all its faults, the PSA test is, at present, ”the best we have.” We look forward, eagerly, to a far better replacement.
Most days the wise man will try to learn something he didn’t know when he got up that morning. Sometimes that can be hard work. This morning your correspondent got lucky.
A couple of weeks ago, as noted on this site and in many places elsewhere, Richard J. Ablin, PhD, wrote an OpEd in the New York Times that was received with surprise in some quarters, agreement by not a few, and a great deal of anger in others. But there was something behind this OpEd that The “New” Prostate Cancer InfoLink did not know until this morning so first and foremost here are a couple of links you might want to look at:
Most of the readers of Prof. Ablin’s original OpEd will not have been aware of at least some of the information on these two sites. That would seem to your correspondent to be a great pity, particularly given the fact that Prof. Ablin himself most certainly did first note the existence of antigens to human prostate tissue some 7 years prior to his father’s diagnosis with metastatic disease in 1978.
The “New” Prostate Cancer InfoLink offers its belated condolences to the Ablin family for the demise of Robert Benjamin Ablin.
Like Prof. Ablin, we have long believed that the PSA test is not a test that should be used in the annual, mass, population-based “screening” of all men for prostate cancer. On the other hand, there are most certainly men who for a wide variety of reasons may benefit from regular (and even annual) PSA testing in order to seek the possibility of avoiding what happened to Prof. Ablin’s father.
For all its faults, the PSA test is, at present, ”the best we have.” We look forward, eagerly, to a far better replacement.